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the activity level from periods of enforced rest to periods of scripted
activity (3). Finally, we could generate similar SDANN values by
dual-chamber pacing whether driven by sinus node activity or by a
mechanical activity sensor (4). Taken together, these findings
indicate the major role of activity in inducing SDANN.
Fantoni et al. found that the increases in SDANN were parallel
to improvements in functional capacity, and Adamson et al. (5)
reported that a decline in physical activity corresponded with a
decrease in SDANN prior to a clinical deterioration.
We propose that patients with successful CRT experience
hemodynamic improvements, an improvement in functional ca-
pacity, and an increase in physical activity with the resultant
modulation of heart rate, which is reflected by an increase in
SDANN. Finally, none of this diminishes the importance of
SDANN, but does suggest that its important role may not involve
the autonomic nervous system.
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REPLY
We appreciate the important comments made by Sheldon et al.
who questioned our interpretation (1) that changes in the standard
deviation of the averages of intrinsic intervals in the 288 5-minute
segments of a day (SDANN) could reflect changes in autonomic
interactions on the heart. The criticism was based on the obser-
vation—provided by their own laboratory—that SDANN is “pos-
sibly and partly” affected by physical activity. We regret to have
overlooked their work (2), which showed that increased level of
physical activity is a possible source of the observed increase in
24-h SDANN; yet this does not imply at all that SDANN is not
an index of autonomic modulation of the heart.
Although our understanding of the physiological background of
long-term, in comparison with short-term, heart rate variability
(HRV) is more incomplete, there is ample evidence that the
autonomic nervous system also plays a major role in the genera-
tion of long-term HRV. Indeed, parasympathetic blockade with
atropine decreases 24-h HRV at all frequencies (3); after heart
transplantation, long-term HRV is reduced at all frequencies (4),
and long-term HRV is also depressed in the autonomic neuropa-
thy occurring in diabetic patients (5).
Though short-term time-domain HRV is substantially dependent
on respiratory arrhythmia and fast baroreflex regulation, long-term
measures have been regarded as reflecting the response of cardiac
regulation to challenges of daily life. Several factors have been invoked
to explain some limitations in the correlation between short- and
long-term HRV, including slower fluctuations due to baroreflexes,
neurohormonal rhythms and circadian patterns, differences between
day and night, and both physical and mental activity.
The role of a deranged baroreflex in affecting autonomic outflow to
the heart is firmly established. For example, a reduced left ventricular
function depresses baroreflex sensitivity and reduces SDNN (6). The
hemodynamic improvement brought about by cardiac resynchroniza-
tion therapy restores cardiac contractility, which results in an improve-
ment in baroreceptor activity and in long-term HRV. Whereas we
cannot exclude that an increase in physical activity might have
contributed to the observed improvement in long-term HRV, we
believe that the autonomic nervous system is the primary determinant
of HRV in both the short and long term.
In conclusion, we do not entirely share the view by Sheldon and
colleagues that the role of SDNN does not involve the autonomic
nervous system.
*Angelo Auricchio, MD, PhD
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